Figure 3From: Calibration of an intrahost malaria model and parameter ensemble evaluation of a pre-erythrocytic vaccine The two pre-erythrocytic vaccine models evaluated: 80% efficacy with nine-month halflife and 60% efficacy with three-year halflife. Back to article page
